| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |